🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo (2.5-60.mg) oral capsule

Found 11 matching trials

A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088

PHASE1

This is the first study of single and multiple doses of IFB-088 in human su...

Status

Completed

Location

Eurofins|Optimed

Start Date

2018-06-21

Trial ID

NCT03610334

Treatments Being Tested

IFB-088 (2.5-60.0mg) oral capsule Placebo (2.5-60.mg) oral capsule IFB-088 (15.0-50.0mg) oral capsule Placebo oral (15.0-50.0mg) capsule

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

PHASE2

The purpose of this study is to try to find the best dose of the new drug B...

Status

Completed

Location

Medizinische Universität Graz

Start Date

2020-01-30

Trial ID

NCT04218266

Treatments Being Tested

BAY2433334 Apixaban BAY2433334 matching placebo Apixaban matching placebo

Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy

PHASE2

The bilateral sagittal split osteotomy (BSSO) of the mandible is one of the...

Status

Unknown

Location

Multiple Locations

Start Date

2022-09-30

Trial ID

NCT05536596

Treatments Being Tested

Orthognathic Surgery Melatonin 10 MG Oral Tablet Hydroxycobalamin Centrum

Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients

PHASE4

Acne Vulgaris is one of the most common dermatologic diagnoses requiring lo...

Status

Completed

Location

East Avenue Medical Center

Start Date

2018-12-21

Trial ID

NCT05096312

Treatments Being Tested

Zinc gluconate Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo]Placebo

Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder

PHASE3

The purpose of the study is to evaluate the efficacy and the tolerability o...

Status

Completed

Location

Multiple Locations

Start Date

2008-02

Trial ID

NCT00635219

Treatments Being Tested

Placebo Vortioxetine (Lu AA21004)Vortioxetine (Lu AA21004)Vortioxetine (Lu AA21004)Duloxetine

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

PHASE3

The purpose of this study is to determine the efficacy and safety of vortio...

Status

Completed

Location

Multiple Locations

Start Date

2008-04

Trial ID

NCT00672620

Treatments Being Tested

Vortioxetine Duloxetine Placebo

Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

PHASE3

The purpose of this study is to determine the safety and efficacy of vortio...

Status

Completed

Location

Multiple Locations

Start Date

2008-06

Trial ID

NCT00730691

Treatments Being Tested

Placebo Vortioxetine Duloxetine

Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome

PHASE4

Burning Mouth Syndrome (BMS) is characterized by a burning sensation on the...

Status

Completed

Location

Federal university of minas gerais

Start Date

2023-11-01

Trial ID

NCT06040190

Treatments Being Tested

topical placebo rinse topical clonazepam rinse oral alpha-lipoic acid capsule topical phytotherapic capsaicin gel local photobiomodulation

A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the safety, tolerability and Pharm...

Status

Completed

Location

PAREXEL Internatonal

Start Date

2013-08

Trial ID

NCT01954238

Treatments Being Tested

GCC-4401C Rivaroxaban Placebo

NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers

PHASE3

This is a multi-centre, long term, double blind, clinical protocol for Nana...

Status

Unknown

Location

Multiple Locations

Start Date

2023-11

Trial ID

NCT04808531

Treatments Being Tested

NanaBis™Oxycodone CR Placebo Spray Placebo Tablet Oxycodone IR

Previous Next